A Two-Drug Combination for Weight Loss
The new medication Contrave, which combines the opioid-receptor antagonist naltrexone (ReVia and others) with the antidepressant and smoking cessation compound bupropion (Wellbutrin, Zyban, and others), has been approved as an adjunct to diet and increased exercise for certain overweight and obese patients.
Clozapine Trumps Polypharmacy
For patients with schizophrenia, clozapine (Clozaril and others) is associated with lower costs and reduced disease-specific emergency department use.
Brain Activity in Men and Women Differs in Response to Cigarette Smoking; Patients with Anxiety Disorders Are at Greater Risk of Hypertension than the General Population
Lack of Cataracts with Quetiapine
Despite warnings about cataracts, quetiapine (Seroquel) actually appears to have a low risk of causing cataracts.
March 31, 2015 is the deadline for returning your 2014 CME posttest to earn up to 12.0 hours of category 1 credit.
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders
Register now, or if you are completing your residency and received a promotional mailing, enter your code.
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
Dr. Gelenberg invites you to join him in Tucson, AZ the week of February 16, 2015 for the 2015 Update on Psychiatry conference. This 4-day live multi-accredited conference will be held at the JW Marriott Starr Pass. This year's program features outstanding speakers from our University and academic institutions around the country including Dr. Alan Gelenberg. Current clinical practices and research focusing on a variety of psychopharmacology topics will be addressed.
For more information and to register go to www.psychopharm.arizona.edu.
Question please contact Leticia Lovallo at email@example.com or 520.626.1392
- J. Rutherford, M.D.